3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
10
Multiple Myeloma
7
Glioma
6
Neoplasm Metastasis
5
Lymphoma
5
Hematologic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Neurofibromatosis 1
4
Pancreatic Neoplasms
3
Neoplasms
3
Colorectal Neoplasms
3
Thyroid Neoplasms
2
Neurofibroma, Plexiform
2
Lung Neoplasms
2
Leukemia, Myelomonocytic, Juvenile
2
Glioblastoma
2
Brain Neoplasms
2
Astrocytoma
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Sarcoma
1
Refractory Differentiated Thyroid Gland Carcinoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
Specimen Handling
4
Gemcitabine
4
Fluorouracil
4
Bevacizumab
4
fludarabine
3
aldesleukin
3
Radiosurgery
3
Oxaliplatin
3
Endoscopic Mucosal Resection
3
Cyclophosphamide
3
Cetuximab
3
130-nm albumin-bound paclitaxel
3
Tomography, X-Ray Computed
2
Surveys and Questionnaires
2
Sunitinib
2
Pemetrexed
2
Leucovorin
2
IDRX-42
2
Folfox protocol
2
Endoscopy, Digestive System
2
Biopsy
2
trastuzumab deruxtecan
1
tislelizumab
1
sodium thiosulfate
1
sodium propionate
1
semaglutide
1
s-formylglutathione hydrolase
1
repotrectinib
1
regorafenib
1
plecanatide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
trametinib
×
90 days
×
Clear all
No trials found.